Page last updated: 2024-08-25

2-bromopalmitate and Breast Neoplasms

2-bromopalmitate has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, LC; Hou, J; Hsu, JL; Hsu, JM; Hung, MC; Li, CW; Qiu, Y; Sun, L; Wei, Y; Xia, W; Yang, Y1
Fox, T; Heakal, Y; Kester, M; Levenson, R; Seaton, K; Woll, MP1

Other Studies

2 other study(ies) available for 2-bromopalmitate and Breast Neoplasms

ArticleYear
Palmitoylation stabilizes PD-L1 to promote breast tumor growth.
    Cell research, 2019, Volume: 29, Issue:1

    Topics: Acyltransferases; Adenocarcinoma; Animals; B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; HEK293 Cells; Humans; Lipoylation; Mice; Mice, Inbred BALB C; Palmitates; Prognosis; Protein Stability

2019
Neurotensin receptor-1 inducible palmitoylation is required for efficient receptor-mediated mitogenic-signaling within structured membrane microdomains.
    Cancer biology & therapy, 2011, Sep-01, Volume: 12, Issue:5

    Topics: Apoptosis; Breast Neoplasms; Cell Line; Cell Membrane; Extracellular Signal-Regulated MAP Kinases; Female; Glycosylation; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Lipoylation; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neurotensin; Palmitates; Phosphorylation; Receptors, Mitogen; Receptors, Neurotensin; Tunicamycin

2011